Tubulin

Class

Small molecule synthetic microtubule-destabilizing agent (spindle poison)

Pathway

Microtubule dynamics disruption / mitotic spindle assembly checkpoint; engineered to evade P-glycoprotein-mediated multidrug resistance

Tubulin is the structural protein that polymerizes into microtubules, the filaments that build the mitotic spindle, the machinery cells use to separate chromosomes during division. Because tumor cells divide more frequently than most normal tissues, agents that interfere with microtubule dynamics preferentially arrest actively cycling cancer cells in mitosis, triggering cell death. This class of molecule is called a spindle poison, and it belongs to the microtubule-destabilizing subgroup, meaning it favors disassembly of microtubules rather than locking them into a rigid, overstable state, which is the opposite strategy used by microtubule-stabilizing agents. Both approaches converge on the same outcome: a cell unable to properly form or resolve its spindle cannot complete division and undergoes apoptosis. A recurring obstacle in this drug class is that many tumor cells develop or express pumps such as P-glycoprotein, which actively export drug molecules and reduce intracellular exposure, producing broad multidrug resistance. Agents engineered to be poor substrates for this pump aim to retain activity in tumors that have become resistant to earlier microtubule-targeting therapies. Because rapidly dividing cells are the shared vulnerability being exploited, this mechanism has broad relevance across solid and hematologic cancers, particularly in settings where prior tubulin-targeted or other cytotoxic therapy has failed.